SERPINE1 and breast cancer: Using Kaplan–Meier analysis and a Cox proportional hazard model, the authors reported that an elevated plasma PAI-1 level had a negative prognostic impact in terms of both relapse-free (RFS) and OS and serves as an independent biomarker for predicting the disease outcome in breast cancer patients [27].